P3 Health Partners (PIII) Preferred Stock Liabilities (2019 - 2021)
P3 Health Partners' (PIII) quarterly Preferred Stock Liabilities came in at $47.0 million in Q4 2021, up 7.75% on a QoQ basis from $43.7 million in Q3 2021.
Powered by 
Analysis
P3 Health Partners (PIII) Preferred Stock Liabilities (2019 - 2021) Analysis & Trends
P3 Health Partners (PIII) has 2 years of Preferred Stock Liabilities data on file, last reported at $47.0 million in Q4 2021.
- Quarterly Preferred Stock Liabilities changed N/A year-over-year to $47.0 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $47.0 million (changed N/A YoY) and the FY2021 annual result came in at $47.0 million, changed N/A from the prior year.
- Preferred Stock Liabilities grew to $47.0 million in Q4 2021, from $43.7 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $47.0 million in Q4 2020 to a low of $43.7 million in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | - |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | - |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | - |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | - |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | P3 Health Partners | 31.00 Mn | 8.78 Mn | 86.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 2, 2021 | 47.04 Mn |
| Sep 30, 2021 | 47.04 Mn |
| Jun 30, 2021 | 47.04 Mn |
| Mar 31, 2021 | 47.04 Mn |
| Dec 31, 2020 | 47.04 Mn |
| Dec 31, 2019 | 47.56 Mn |